Azopt 1%
Azopt 1%
$57.99
Earn 3 points upon purchasing this product.
5ml
Azopt
Azopt is a form of medicine that treats ocular hypertension and glaucoma. It is available under the generic name Brinzolamide Ophthalmic.
Uses of Azopt
By consuming this medicine, the fluid pressure inside the eyes is reduced. This process prevents the mentioned medical conditions from taking place. Azopt prevents further damages inside the eyes and alleviates symptoms that correspond to the condition.
Azopt Precautions and Warnings
Before using this medicine, ensure that you have provided your healthcare professional with your medical history, underlying health concerns, and even allergies to different medications.
If you happen to be allergic to this medicines’ main ingredient, do not use it. Also, ensure that your healthcare professional if you have the following conditions: kidney disease and narrow-angle glaucoma.
Azopt Dosage
Just like other eye drops, shake the bottle first before using it. The required treatment is 1 drop to the affected eye, which should be performed twice a day. For dosage adjustment, your healthcare professional will be the one to suggest it. Sometimes, the dosage will increase to 3 drops daily. Furthermore, always follow the prescription given by your healthcare professional to ensure successful treatment.
Azopt Side Effects
Similar to other eye drops, Azopt can also give patients a series of side effects. These include the following:
Common Side Effects of Azopt
- Itchiness
- Blurry vision
- Runny nose
- Mild headache
- Discharge from the eyes
Severe Side Effects of Azopt
- Breathing difficulty
- Redness of the eyes
- Wheezing
- Skin rashes
- Irregular heartbeat
Only logged in customers who have purchased this product may leave a review.
Cart
Product Search
Product Categories
Top Rated Products
-
Abilify 2mg
$129.89
-
Osteofos 70mg (India)
$43.91
-
Arnuity Ellipta Inhaler 100mcg
$64.99
-
Nebistar 2.5mg (India)
$42.99
-
Tadalafil 2.5mg
$69.99
-
Combigan 0.2/0.5% (Turkey)
$32.37
Reviews
There are no reviews yet.